Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 7;5(4):e669.
doi: 10.1002/hsr2.669. eCollection 2022 Jul.

Neurocognitive decline as a major predictor of nonadherence to antiretroviral therapy among adults living with HIV in Dodoma region, central Tanzania

Azan A Nyundo  1
Affiliations

Neurocognitive decline as a major predictor of nonadherence to antiretroviral therapy among adults living with HIV in Dodoma region, central Tanzania

Azan A Nyundo. Health Sci Rep. .

Abstract

Background: The survival of people living with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome largely depends on good adherence to antiretroviral medications. Neuropsychiatric conditions such as major depressive disorders (MDDs) and neurocognitive disorders, in particular, are common in the HIV population and attributed to suboptimal adherence to antiretroviral treatment and overall poor clinical outcomes. This study aimed to determine the association between neurocognitive disorders and nonadherence to antiretroviral therapy (ART) in the Dodoma region's adult population living with HIV.

Methods: The study was conducted in Dodoma Regional Referral Hospital using a cross-sectional design to assess 397 participants through a systematic sampling approach. Montreal Cognitive Assessment was used to determine neurocognitive function, while the Simplified Medical Adherence Questionnaire was used to assess nonadherence to ART. Logistic regression analysis was computed to determine the association between cognitive decline and nonadherence to ART while controlling for sociodemographic and clinical confounders.

Results: Out of the 397 recruited participants, 266 (67.00%) and 41 (10.33%) met the criteria for neurocognitive decline and nonadherence to ART. Participants with cognitive impairment had a significantly poorer adherence rate than those without, even after controlling for confounders adjusted odds ratio (aOR): 2.183 (95% confidence interval [CI]: 1.031, 4.630, p = 0.0413). MDD was the only additional factor that remained significantly associated with ART nonadherence (aOR: 4.332, 95% CI: 1.634, 11.485, p = 0.0032).

Conclusion: Neurocognitive disorders are strong predictor of suboptimal adherence to ART; a comorbid neuropsychiatric condition such as MDD may further compromise the ART adherence rate leading to poor HIV care and poor clinical outcome. Further research with systematic and more robust studies in the field will provide a baseline to design and integrate appropriate care models to maximize ART adherence in HIV care. Integration of psychiatric services in HIV care can benefit the overall patient outcome.

Keywords: ART nonadherence; HIV/AIDS; neurocognitive decline.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Prevalence of ART‐nonadherence and association with neurocognitive status. ART, antiretroviral therapy.
See this image and copyright information in PMC

References

    1. Mekuria LA, Prins JM, Yalew AW, Sprangers MAG, Nieuwkerk PT. Retention in HIV care and predictors of attrition from care among HIV‐infected adults receiving combination anti‐retroviral therapy in Addis Ababa. PLoS One. 2015;10(6):e0130649. - PMC - PubMed
    1. Giordano TP, Gifford AL, White AC, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007;44(11):1493‐1499. - PubMed
    1. Pennar A, Naar S, Woods S, Nichols S, Outlaw A, Ellis D. Promoting resilience through neurocognitive functioning in youth living with HIV. AIDS Care. 2018;30(suppl 4):59‐64. - PubMed
    1. McLean CP, Gay NG, Metzger DA, Foa EB, Penn Mental Health AIDS Research Center . Psychiatric symptoms and barriers to care in HIV‐infected individuals who are lost to care. J Int Assoc Provid AIDS Care. 2017;16(5):423‐429. - PMC - PubMed
    1. Grant I, Franklin DR, Deutsch R, et al. Asymptomatic HIV‐associated neurocognitive impairment increases the risk for symptomatic decline. Neurology. 2014;82(23):2055‐2062. - PMC - PubMed

LinkOut - more resources